University of California San Francisco Children's Hospital
Welcome,         Profile    Billing    Logout  
 19 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Keller, Roberta L
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry

Recruiting
N/A
2500
Canada, US
University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
12/30
12/31
Fineman, Jeffrey R
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension

Recruiting
3
100
Canada, US
Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS)
Pediatric Pulmonary Hypertension
09/26
09/26
PHAR, NCT04071327: Pulmonary Hypertension Association Registry

Recruiting
N/A
3000
US
Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
10/25
10/25
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry

Recruiting
N/A
2500
Canada, US
University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
12/30
12/31
Tacy, Theresa A
NCT04474223: Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Recruiting
3
1300
Canada, US
Dexamethasone, IVIG
NYU Langone Health
AVB - Atrioventricular Block, Fetal AVB
08/26
10/26
Cowan, Morton J
NCT03538899: Autologous Gene Therapy for Artemis-Deficient SCID

Recruiting
1/2
25
US
AProArt-CD34, lentiviral gene therapy using AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan, Busulfex
University of California, San Francisco
Severe Combined Immunodeficiency
06/38
06/38
NCT01346150: Patients Treated for SCID (1968-Present)

Enrolling by invitation
N/A
1007
Canada, US
National Institute of Allergy and Infectious Diseases (NIAID), Primary Immune Deficiency Treatment Consortium (PIDTC), National Center for Advancing Translational Sciences (NCATS)
SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
08/23
08/23
NCT01186913: Natural History Study of SCID Disorders

Enrolling by invitation
N/A
690
Canada, US
National Institute of Allergy and Infectious Diseases (NIAID), Primary Immune Deficiency Treatment Consortium (PIDTC), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS)
Severe Combined Immunodeficiency (SCID), Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA SCID, XSCID
09/28
09/28
Dvorak, Christopher
CSIDE, NCT03619551: Conditioning SCID Infants Diagnosed Early

Recruiting
2
64
Canada, US
Busulfan, Cell processing for TCRαβ+/CD19+ depletion, CliniMACS
Michael Pulsipher, MD
SCID
08/26
08/26
BRIDGE, NCT05787574: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Recruiting
2
39
US
Emapalumab, Fludarabine and Dexamethasone, Stem Cell Transplant
Memorial Sloan Kettering Cancer Center, Sobi, Inc.
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases
03/27
03/27
NCT02963064: JSP191 Antibody Targeting Conditioning in SCID Patients

Recruiting
1/2
40
US
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper Therapeutics, Inc.
SCID
06/25
06/28
NCT02617407: Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Completed
1
44
US
Livionex® Dental Gel, Edathamil, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Over the counter toothpaste, Kolibree Toothbrush
University of California, San Francisco
Dental Plaque
01/20
01/20
NCT01200017: Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

No Longer Available
N/A
US
CD34+ enriched, T Cell Depleted donor stem cell product, bone marrow transplant
Christopher Dvorak
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Lymphomas, Bone Marrow Failure, Hemoglobinopathy, Immune Deficiency, Osteopetrosis, Cytopenias, Leukocyte Disorders, Anemia Due to Intrinsic Red Cell Abnormality
 
 
NCT03718546: Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Active, not recruiting
N/A
754
US
Center for International Blood and Marrow Transplant Research, University of Pittsburgh
Quality of Life
08/24
08/24
NCT01186913: Natural History Study of SCID Disorders

Enrolling by invitation
N/A
690
Canada, US
National Institute of Allergy and Infectious Diseases (NIAID), Primary Immune Deficiency Treatment Consortium (PIDTC), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS)
Severe Combined Immunodeficiency (SCID), Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA SCID, XSCID
09/28
09/28
NCT04337515: A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Recruiting
N/A
90
US
CliniMacs®, CliniMACS® CD34 Reagent System
Christopher Dvorak
Graft Vs Host Disease, Graft-versus-host-disease
01/30
01/35
Moore, Phillip
No trials found
Dunn, Elizabeth
No trials found
Bani, Tara
No trials found

Download Options